Web Analysis for Sareptatherapeutics - sareptatherapeutics.com
We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.
sareptatherapeutics.com is 2 decades 3 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, sareptatherapeutics.com is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Excellent |
WOT Child Safety: | Excellent |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | 3 | H2 Headings: | 7 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 14 |
Google Adsense: | Not Applicable | Google Analytics: | UA-33339726-1 |
Websites Hosted on Same IP (i.e. 54.204.43.126)
Sarepta Therapeutics | Focused on precision genetic medicines to treat
Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 5 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders, totali
The Leader in RNA-based Medicine | Sarepta Therapeutics
We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.
HTTP Header Analysis
Server: nginx
Content-Type: text/html; charset=utf-8
X-Drupal-Cache: HIT
Etag: "1420139019.692-0"
X-Content-Type-Options: nosniff
X-Frame-Options: SameOrigin
Content-Language: en
X-Generator: Drupal 7 (http://drupal.org)
Link: <http://www.sarepta.com/>; rel="canonical",<http://www.sarepta.com/>; rel="shortlink"
Cache-Control: public, max-age=300
Last-Modified: Thu, 01 Jan 2015 19:03:39 +0000
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: v-6cbf64da-91ef-11e4-9ff9-1231380716a8
X-AH-Environment: prod
Content-Encoding: gzip
Content-Length: 8293
Accept-Ranges: bytes
Date: Thu, 01 Jan 2015 19:54:49 GMT
X-Varnish: 1824175316 1824175204
Age: 266
Via: 1.1 varnish
Connection: keep-alive
X-Cache: HIT
X-Cache-Hits: 3
Domain Information
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
sareptatherapeutics.com | A | 3594 |
IP: 54.204.43.126 |
sareptatherapeutics.com | NS | 3599 |
Target: dns3.easydns.org |
sareptatherapeutics.com | NS | 3599 |
Target: dns4.easydns.info |
sareptatherapeutics.com | NS | 3599 |
Target: dns2.easydns.net |
sareptatherapeutics.com | NS | 3599 |
Target: dns1.easydns.com |
sareptatherapeutics.com | SOA | 3599 |
MNAME: dns1.easydns.com RNAME: zone.easydns.com Serial: 1410380098 Refresh: 43200 Retry: 10800 Expire: 604800 Minimum TTL: 3600 |
sareptatherapeutics.com | MX | 3599 |
Priority: 10 Target: cluster1.us.messagelabs.com |
sareptatherapeutics.com | MX | 3599 |
Priority: 20 Target: cluster1a.us.messagelabs.com |
sareptatherapeutics.com | TXT | 3599 |
TXT: v=spf1 a:mail.sarepta.com a:cluster1.us.messagelabs.com a:cluster1a.us.messagela bs.com ~all |